Mirae Asset Global Investments’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84K | Buy |
4,855
+655
| +16% | +$11.3K | ﹤0.01% | 1171 |
|
|
2025
Q1 | $102K | Buy |
4,200
+55
| +1% | +$1.34K | ﹤0.01% | 1126 |
|
|
2024
Q4 | $135K | Sell |
4,145
-259
| -6% | -$8.46K | ﹤0.01% | 1107 |
|
|
2024
Q3 | $130K | Buy |
4,404
+781
| +22% | +$23K | ﹤0.01% | 1152 |
|
|
2024
Q2 | $150K | Sell |
3,623
-46,676
| -93% | -$1.94M | ﹤0.01% | 1089 |
|
|
2024
Q1 | $3.22M | Buy |
+50,299
| New | +$3.22M | 0.01% | 1012 |
|
|
2023
Q2 | – | Sell |
-50,462
| Closed | -$3.33M | – | 2606 |
|
|
2023
Q1 | $3.33M | Buy |
50,462
+5,283
| +12% | +$348K | 0.01% | 983 |
|
|
2022
Q4 | $2.34M | Buy |
45,179
+2,291
| +5% | +$118K | 0.01% | 1076 |
|
|
2022
Q3 | $2.93M | Buy |
42,888
+14,162
| +49% | +$967K | 0.01% | 995 |
|
|
2022
Q2 | $1.3M | Buy |
+28,726
| New | +$1.3M | ﹤0.01% | 1285 |
|